These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9822286)

  • 1. Human intravenous immunoglobulin (IVIG) preparations degranulate human neutrophils in vitro.
    Teeling JL; De Groot ER; Eerenberg AJ; Bleeker WK; Van Mierlo G; Aarden LA; Hack CE
    Clin Exp Immunol; 1998 Nov; 114(2):264-70. PubMed ID: 9822286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimeric IgG complexes from IVIg are incapable of inducing in vitro neutrophil degranulation or complement activation.
    Kustiawan I; Derksen NIL; Guhr T; Kruithof S; Jiskoot W; Vidarsson G; Rispens T
    PLoS One; 2018; 13(4):e0195729. PubMed ID: 29634774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulins contain naturally occurring antibodies that mimic antineutrophil cytoplasmic antibodies and activate neutrophils in a TNFalpha-dependent and Fc-receptor-independent way.
    Jarius S; Eichhorn P; Albert MH; Wagenpfeil S; Wick M; Belohradsky BH; Hohlfeld R; Jenne DE; Voltz R
    Blood; 2007 May; 109(10):4376-82. PubMed ID: 17264299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin preparations induce mild activation of neutrophils in vivo via triggering of macrophages--studies in a rat model.
    Teeling JL; Bleeker WK; Rigter GM; van Rooijen N; Kuijpers TW; Hack CE
    Br J Haematol; 2001 Mar; 112(4):1031-40. PubMed ID: 11298603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations.
    Altznauer F; von Gunten S; Späth P; Simon HU
    J Allergy Clin Immunol; 2003 Dec; 112(6):1185-90. PubMed ID: 14657880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IVIG regulates the survival of human but not mouse neutrophils.
    Schneider C; Wicki S; Graeter S; Timcheva TM; Keller CW; Quast I; Leontyev D; Djoumerska-Alexieva IK; Käsermann F; Jakob SM; Dimitrova PA; Branch DR; Cummings RD; Lünemann JD; Kaufmann T; Simon HU; von Gunten S
    Sci Rep; 2017 May; 7(1):1296. PubMed ID: 28465620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monomeric IgG in intravenous Ig preparations is a functional antagonist of FcgammaRII and FcgammaRIIIb.
    van Mirre E; Teeling JL; van der Meer JW; Bleeker WK; Hack CE
    J Immunol; 2004 Jul; 173(1):332-9. PubMed ID: 15210791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin preparations promote apoptosis in lipopolysaccharide-stimulated neutrophils via an oxygen-dependent pathway in vitro.
    Takeshita S; Tsujimoto H; Nakatani K
    APMIS; 2005 Apr; 113(4):269-77. PubMed ID: 15865608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.
    Buchwald B; Ahangari R; Weishaupt A; Toyka KV
    Ann Neurol; 2002 Jun; 51(6):673-80. PubMed ID: 12112071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both the Fab and Fc domains of IgG are essential for ROS emission from TNF-α-primed neutrophils by IVIG.
    Higurashi S; Machino Y; Suzuki E; Suzuki M; Kohroki J; Masuho Y
    Biochem Biophys Res Commun; 2012 Jan; 417(2):794-9. PubMed ID: 22197815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of the biological activities of IgG in seven Chinese intravenous immunoglobulin preparations.
    Ye S; Li D; Liu F; Lei M; Jiang P; Wang Z; Zhang R; Du X; Cao H; Ma L; Li C
    J Pharm Biomed Anal; 2018 Mar; 151():317-323. PubMed ID: 29413980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase.
    Bleeker WK; Teeling JL; Verhoeven AJ; Rigter GM; Agterberg J; Tool AT; Koenderman AH; Kuijpers TW; Hack CE
    Blood; 2000 Mar; 95(5):1856-61. PubMed ID: 10688848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of antigen specificities in the monomeric and dimeric fractions of intravenous immunoglobulin.
    Miescher SM; Schaub A; Ghielmetti M; Baumann M; Vogel M; Bolli R; Stadler B
    Ann N Y Acad Sci; 2005 Jun; 1051():582-90. PubMed ID: 16126998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in signal transduction between Fc gamma receptors (Fc gamma RII, Fc gamma RIII) and FMLP receptors in neutrophils. Effects of colchicine on pertussis toxin sensitivity and diacylglycerol formation.
    Reibman J; Haines KA; Gude D; Weissmann G
    J Immunol; 1991 Feb; 146(3):988-96. PubMed ID: 1846387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes.
    Schaub A; von Gunten S; Vogel M; Wymann S; Rüegsegger M; Stadler BM; Spycher M; Simon HU; Miescher S
    Allergy; 2011 Aug; 66(8):1030-7. PubMed ID: 21385183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment potential of pathogen-reactive antibodies sequentially purified from pooled human immunoglobulin.
    Reglinski M; Sriskandan S
    BMC Res Notes; 2019 Apr; 12(1):228. PubMed ID: 30992057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reactivity in the dimeric intravenous immunoglobulin fraction.
    Schaub A; Wymann S; Heller M; Ghielmetti M; Beleznay Z; Stadler BM; Bolli R; Miescher S
    Ann N Y Acad Sci; 2007 Sep; 1110():681-93. PubMed ID: 17911483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow-cytometric method for the quantitation of the Fc function of intravenous immunoglobulin preparations.
    Ramasamy I; Tran E; Charnock A; Farrugia A
    Vox Sang; 2000; 78(3):185-93. PubMed ID: 10838520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the contents of the magic draft IVIg?
    Seite JF; Shoenfeld Y; Youinou P; Hillion S
    Autoimmun Rev; 2008 Jun; 7(6):435-9. PubMed ID: 18558358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations.
    von Gunten S; Schaub A; Vogel M; Stadler BM; Miescher S; Simon HU
    Blood; 2006 Dec; 108(13):4255-9. PubMed ID: 16902148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.